The pharmaceutical industry has experienced significant growth and change, including increased regulations and oversight. A critical part of the overall healthcare system, the pharmaceuticals industry will only continue to gain importance in the future. Husch Blackwell regularly advises pharmacy benefit managers, drug manufacturers and distributors of prescription and over-the-counter products, pharmacies and medical device organizations, along with other stakeholders in the drug supply chain.
We are one of the only law firms in the country with an entire group devoted to pharmacy benefits and operations. We routinely provide advice on a variety of compliance and regulatory matters, including all aspects of Medicare, Medicaid, state fraud and abuse statutes, the federal anti-kickback law, the Health Insurance Portability and Accountability Act (HIPAA), federal and state procurement laws, and other federal and state laws and regulations.
We advocate for our clients in connection with class actions, multidistrict litigation (MDL), claims for disgorgement of profits, and actions by health insurers and governmental entities. From regulatory counseling to litigation, we understand how to achieve our clients’ business goals, and we provide pragmatic advice and workable solutions. In addition, our clients benefit from our experience and understanding in related U.S. Food and Drug Administration (FDA) and regulatory matters involving marketing approval for generic drugs under the Hatch-Waxman Act, a necessity in crafting patent litigation strategies.
Clients rely on our technical and legal expertise to help them achieve maximum advantage under existing laws and policies, while we work to effectively shape new policies that reflect today’s complex economic realities.
Pharmaceutical industry experience for our clients includes:
Husch Blackwell’s esteemed healthcare team is exceptional at client service.